AXIOS June 4, 2024
The evidence of new obesity and diabetes drugs’ smashing success can now be seen in grocery store aisles.
Why it matters: Food giants are rolling out new and reformulated products appealing to the changing appetites of the fast-growing number of people prescribed drugs like Novo Nordisk’s Ozempic and Wegovy — and experts say this could shift American diets more broadly.
The big picture: It’s thought the drugs known as GLP-1 agonists help patients lose weight by slowing down stomach emptying, allowing them to get full faster and for longer.
- But that can also make it harder to get necessary nutrients, experts say.
- GLP-1 users also have reported changing tastes, with high-fat and sweet foods becoming less appealing for some. ...